FDx Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,508
| Closed | -$627K | – | 860 |
|
|
2023
Q1 | $627K | Hold |
5,508
| – | – | 0.03% | 378 |
|
|
2022
Q4 | $627K | Sell |
5,508
-394
| -7% | -$44.9K | 0.03% | 378 |
|
|
2022
Q3 | $365K | Sell |
5,902
-10,097
| -63% | -$624K | 0.02% | 488 |
|
|
2022
Q2 | $1.28M | Buy |
15,999
+705
| +5% | +$56.2K | 0.05% | 275 |
|
|
2022
Q1 | $1.61M | Sell |
15,294
-837
| -5% | -$88.1K | 0.05% | 244 |
|
|
2021
Q4 | $1.74M | Buy |
16,131
+622
| +4% | +$67K | 0.05% | 248 |
|
|
2021
Q3 | $1.7M | Sell |
15,509
-245
| -2% | -$26.8K | 0.05% | 236 |
|
|
2021
Q2 | $1.48M | Buy |
15,754
+202
| +1% | +$18.9K | 0.05% | 248 |
|
|
2021
Q1 | $1.43M | Buy |
15,552
+8,303
| +115% | +$764K | 0.05% | 218 |
|
|
2020
Q4 | $530K | Buy |
7,249
+693
| +11% | +$50.7K | 0.02% | 428 |
|
|
2020
Q3 | $509K | Buy |
+6,556
| New | +$509K | 0.02% | 370 |
|